Simplex Trading’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-124,000
| Closed | -$90K | – | 9889 |
|
|
2025
Q3 | $90K | Sell |
124,000
-85,300
| -41% | -$437K | ﹤0.01% | 5875 |
|
|
2025
Q2 | $797K | Buy |
209,300
+178,800
| +586% | +$555K | ﹤0.01% | 3021 |
|
|
2025
Q1 | $80K | Sell |
30,500
-3,700
| -11% | -$12.1K | ﹤0.01% | 5302 |
|
|
2024
Q4 | $121K | Buy |
34,200
+5,100
| +18% | +$19.5K | ﹤0.01% | 5005 |
|
|
2024
Q3 | $132K | Sell |
29,100
-2,100
| -7% | -$10.2K | ﹤0.01% | 4944 |
|
|
2024
Q2 | $135K | Buy |
31,200
+600
| +2% | +$2.64K | ﹤0.01% | 5043 |
|
|
2024
Q1 | $153K | Buy |
30,600
+13,200
| +76% | +$73.9K | ﹤0.01% | 5130 |
|
|
2023
Q4 | $109K | Sell |
17,400
-10,500
| -38% | -$60.1K | ﹤0.01% | 5293 |
|
|
2023
Q3 | $198K | Sell |
27,900
-2,000
| -7% | -$15.8K | ﹤0.01% | 4371 |
|
|
2023
Q2 | $304K | Buy |
29,900
+4,100
| +16% | +$42.8K | ﹤0.01% | 3828 |
|
|
2023
Q1 | $234K | Buy |
25,800
+21,200
| +461% | +$155K | ﹤0.01% | 4150 |
|
|
2022
Q4 | $32K | Sell |
4,600
-2,300
| -33% | -$14.1K | ﹤0.01% | 6393 |
|
|
2022
Q3 | $44K | Buy |
+6,900
| New | +$36.9K | ﹤0.01% | 6628 |
|
|
2022
Q1 | – | Sell |
-400
| Closed | -$2K | – | 11279 |
|
|
2021
Q4 | $2K | Sell |
400
-2,600
| -87% | -$14.3K | ﹤0.01% | 10046 |
|
|
2021
Q3 | $21K | Hold |
3,000
| – | – | ﹤0.01% | 8411 |
|
|
2021
Q2 | $18K | Buy |
+3,000
| New | +$18.1K | ﹤0.01% | 8683 |
|
Simplex Trading's SCPH Position: Q4 2025 in Review
Simplex Trading sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 6,504 shares — an estimated $36K sold.
Simplex Trading first reported a position in SCPH in Q4 2021 and held it in 11 quarters. The position peaked at $288K in Q2 2022. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.
- Simplex Trading reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 6,504 scPharmaceuticals shares in Q4 2025, an estimated $36K.
- Simplex Trading first reported a position in scPharmaceuticals in Q4 2021 and held it in 11 quarters.
- Simplex Trading's scPharmaceuticals position peaked at $288K in Q2 2022.
- 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.